Interpretation of 2015 Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group

PI Zhuang; WANG Zhao-xia

doi:10.7504/ek2016070602

Home>Articles>Interpretation of 2015 Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group

DOI: 10.7504/ek2016070602

Interpretation of 2015 Use of Biosimilars in Paediatric Inflammatory Bowel Disease: A Position Statement of the ESPGHAN Paediatric IBD Porto Group

PI Zhuang

WANG Zhao-xia

Keywords：biosimilarinflammatory bowel diseaseinfliximabpaediatricposition paper

Publication Date：2016-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Chinese Journal of Practical Pediatrics

PKUISTIC

ISSN：1005-2224

Year, Vol.(Issue)：2016,31(7)